Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial
C M Jespersen, H J Kolmos, N Frydendall,
J Hilden
, C Gluud, J Fischer Hansen, CLARICOR Trial Group
Section of Biostatistics
10
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Events
100%
Stable Coronary Artery Disease
100%
Clarithromycin
100%
Placebo
100%
Serious Adverse Events
62%
Non-serious
50%
Gastrointestinal Side Effects
25%
Placebo Groups
25%
Chronic Coronary Artery Disease
12%
Cardiovascular Events
12%
Randomized Placebo-controlled Trial
12%
Days of Treatment
12%
Treatment-related Adverse Events
12%
Randomized Clinical Trial
12%
Hospitalization
12%
No Significant Difference
12%
Cardiovascular Mortality
12%
Increased Mortality
12%
First Month
12%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Adverse Event
100%
Ischemic Heart Disease
100%
Coronary Artery Disease
10%
Tablet
10%
Randomized Clinical Trial
10%